Sciton Unveils Newest Aesthetic Platform, mJOULE™ Featuring BBL HERO™ And MOXI™

Sciton: This historic new product launch, on the much-anticipated platform mJOULE, includes a new fractional treatment, MOXI, and BBL HERO, the biggest advancement in the history of pulsed light-based technology.

Radiant Skin From Head To Toe
Created in response to market demand, mJOULE is a dual-wavelength platform designed to fit any practice. The platform houses the latest non-ablative fractional wavelength, MOXI, and the fastest, most powerful IPL in the industry, BBL HERO (High Energy Rapid Output). BBL HERO allows practitioners to treat the entire body with four times the speed, three times the peak power and two times the cooling capacity.

“1927 nm is a winner, BBL plus 1927nm (MOXI) equals an awesome, delegatable treatment,” states Elizabeth L. Tanzi, M.D. FAAD, Director Capital Laser and Skin Care. “Between Sciton’s MOXI, HALO and Erbium Fully Ablative Laser Platform, all the resurfacing options are covered by one company. It’s the full toolbox.”

The MOXI Magic
MOXI is a laser skin revitalization treatment that is as bold as the patients it was created to treat. With extensive market research, MOXI was developed for active individuals looking to correct the initial signs of sun damage and aging by fixing uneven pigmentation and improving the general tone and texture of skin. Improvements can be noticed after a single treatment. MOXI is a superb addition to an ongoing skin treatment regimen for men and women looking to maintain a youthful appearance.

“The mJOULE’s MOXI addresses a gap in treatment offerings by delivering a time effective solution for our customers, a progressive alternative for their patients and an exciting advancement in our field,” states Robb Brindley, Sciton Vice President of North American Sales.

MOXI comfortably delivers non-ablative laser energy to revitalize skin, no matter the season, age or skin type. Taking under 30 minutes, this ideal lunchtime treatment has little to no downtime and fits into an active lifestyle at any time of the year.

A HERO Gets The Job Done
Sciton’s BroadBand Light is well known in the industry for being the most robust and powerful IPL. With the release of the groundbreaking BBL HERO, Sciton elevates the market yet again. HERO treats the entire body with Forever Young BBL+™ and Forever Body™, designed to deliver dramatic tonal and textural improvements anywhere on the body in a quarter of the time.

“BBL HERO is the most significant advance in pulsed broad-spectrum light in 20 years,” says board-certified dermatologist, Patrick Bitter, MD, who is excited to add the game-changing technology to his Los Gatos practice. “When my patients look at their skin post-treatment they just say, ‘AMAZING!’ They are seeing smoother, clearer, younger, and healthier-looking skin after just one treatment with BBL HERO.”

“At Sciton we work hand in hand with our physician partners to drive visionary innovation that is founded on science and uncompromised in quality,” shares Mr. Brindley. “We are proud to lead the industry, leaving competitors by the wayside with proven technologies that benefit practices and patients alike. The future of aesthetic medicine is brighter than ever, and we are well-positioned to release multiple products during a critical time in our industry.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”